Department of Cardiology, Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham B15 2TH, UK.
Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.
Europace. 2020 Jun 1;22(6):956-963. doi: 10.1093/europace/euaa008.
Incidental left bundle branch block (iLBBB) is a frequent cause for cardiology referrals. In such instances, there is uncertainty as to its prognosis. We sought to determine the utility of cardiovascular magnetic resonance (CMR) in the risk stratification of patients with iLBBB.
Clinical events were collected in patients with iLBBB who had CMR. Controls had no cardiac symptoms or cardiac disease, a normal CMR scan and electrocardiogram. Amongst patients with iLBBB [n = 193, aged 62.7 ± 12.6 years (mean ± SD)], 110/193 (56.9%) had an abnormal phenotype (iLBBBCMR+) and 83/110 (43.0%) had a normal phenotype (iLBBBCMR-). Over 3.75 years (median; inter-quartile range: 2.7-5.5), iLBBBCMR+ had a higher total mortality [adjusted hazard ratio (aHR) 6.49, 95% confidence interval (CI) 1.91-22.0] and total mortality or major adverse cardiac events (MACEs; aHR 9.15, 95% CI 2.56-32.6) than controls (n = 107). In contrast, iLBBBCMR- had a similar risk of total mortality compared with controls, but total mortality or MACEs was higher (aHR 4.24, 95% CI 1.17-15.4; P = 0.028). Amongst iLBBB patients, both myocardial fibrosis (aHR 5.15, 95% CI 1.53-17.4) and left ventricular ejection fraction (LVEF) ≤ 50% (aHR 3.88, 95% CI 1.67-9.06) predicted total mortality. Myocardial fibrosis plus LVEF ≤50% was associated with the highest risk of total mortality (aHR: 9.87, 95% CI 2.99-32.6) and total mortality or MACEs (aHR 3.98, 95% CI 1.73-9.11).
Outcomes in iLBBBCMR+ were poor whereas survival in iLBBBCMR- was comparable with controls. Myocardial fibrosis and LVEF <50% had an additive effect on the risk of clinical outcomes. A CMR scan is pivotal in risk-stratifying patients with iLBBB.
偶然出现的左束支传导阻滞(iLBBB)是心内科转诊的常见原因。在这种情况下,其预后存在不确定性。我们旨在确定心血管磁共振(CMR)在 iLBBB 患者风险分层中的作用。
对接受 CMR 检查的 iLBBB 患者进行临床事件采集。对照组无心脏症状或心脏疾病,心电图和 CMR 检查正常。在 iLBBB 患者中[n=193,年龄 62.7±12.6 岁(均值±标准差)],110/193(56.9%)存在异常表型(iLBBBCMR+),83/110(43.0%)表型正常(iLBBBCMR-)。随访 3.75 年(中位数;四分位距:2.7-5.5),iLBBBCMR+的全因死亡率[校正后风险比(aHR)6.49,95%置信区间(CI)1.91-22.0]和全因死亡率或主要不良心脏事件(MACE;aHR 9.15,95%CI 2.56-32.6]高于对照组(n=107)。相比之下,iLBBBCMR-的全因死亡率与对照组相似,但全因死亡率或 MACE 较高(aHR 4.24,95%CI 1.17-15.4;P=0.028)。在 iLBBB 患者中,心肌纤维化(aHR 5.15,95%CI 1.53-17.4)和左室射血分数(LVEF)≤50%(aHR 3.88,95%CI 1.67-9.06)均预测全因死亡率。心肌纤维化合并 LVEF≤50%与全因死亡率(aHR:9.87,95%CI 2.99-32.6)和全因死亡率或 MACE(aHR 3.98,95%CI 1.73-9.11)风险最高。
iLBBBCMR+患者预后不良,而 iLBBBCMR-患者的生存率与对照组相当。心肌纤维化和 LVEF<50%对临床结局风险有叠加作用。CMR 扫描对 iLBBB 患者的风险分层至关重要。